In addition to intersecting with ER, PI3K, and RAS pathways, the cyclin D-CDK4/6-RB pathway is also involved in DNA damage repair (DDR) [40], which makes CDK4/6 inhibitors perfect candidates for tumor radiosensitization. The gene discussed is CDK4; the disease is neoplasm.